References
- FERACCRU®. Summary of Product Characteristics. Available for the UK from: https://www.medicines.org.uk/emc. Available for Northern Ireland from: https://www.emcmedicines.com/en-GB/northernireland/
This website is intended for healthcare professionals. If you are a member of the public, please click here
Each FERACCRU® capsule contains 30 mg iron (as ferric maltol).1
No, FERACCRU® contains lactose which is a milk sugar.1
No, FERACCRU® capsules are an immediate-release formulation.1
FERACCRU® capsules should not be opened. They should be swallowed whole.1
FERACCRU® capsules should not be opened. They should be swallowed whole. We do not have any information on using FERACCRU® for this mode of administration.1
The safety and efficacy of FERACCRU® in children (17 years & under) has not yet been established and so no data is available.1
Yes, FERACCRU® is licensed to treat iron deficiency, with or without anaemia.1
FERACCRU® should be taken whole on an empty stomach (with half a glass of water); do not take with food as this reduces the absorption of iron.1
FERACCRU® should not be used in IBD patients with haemoglobin <9.5g/dL. FERACCRU® has not been studied in these patients.1
The absorption of oral iron may be reduced by calcium and magnesium. They should be given at least 2 hours apart from FERACCRU®.1
Yes. Feraccru may be used during pregnancy if necessary and can be used during breastfeeding if clinically needed.